220 results Stibbe represents Mylan On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition Stibbe advises Tornier Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion. Stibbe advises on the IPO of Pershing Square Holdings Stibbe advises Pershing Square Holdings, Ltd. on the IPO of this investment fund managed by the leading active investor Bill Ackmann. Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business. Stibbe advises Investcorp on the acquisition of SPGPrints Stibbe advises Investcorp, a global provider and manager of alternative investment products, on its acquisition of SPGPrints Group from funds managed by Bencis Capital Partners. Stibbe advises on the acquisition of an Intercontinental hotel portfolio including the landmark Amstel Hotel in Amsterdam Stibbe advised Katara Hospitality QSA (a subsidiary of the Qatar Investment Authority), the Qatar-based global owner, developer and operator of hotels, on the acquisition of five luxury InterContinental properties in key European cities. Stibbe advises Aedifica Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence that will be constructed in Leersum. Aedifica acquired the full property of the site from Woudenburcht B.V., a local real estate developer. See for the press release here. Stibbe represents Simed in dispute with Slotervaart hospital Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b Stibbe advises US asset manager Stibbe advised a US asset manager on securing the acquisition of a real estate portfolio in France via a Luxembourg, non-regulated fund platform. Stibbe advises The Blackstone Group Stibbe advises The Blackstone Group. Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products. Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital. Stibbe advises leading US car rental company Stibbe advised a leading US car rental company on Luxembourg company law aspects related to its acquisition of PSA Peugeot Citroën’s car rental subsidiary, Citer SA and its Spanish subsidiary Atesa through a Luxembourg structure. Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding. Stibbe advises the Port of Antwerp Stibbe advised the Port of Antwerp International on its strategic partnership with Essar Ports Ltd. which is India’s second largest private sector ports operator, and on PAI's investment into EPL. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises on the contemplated IPO of Agendia Pagination Previous page Page 10 Current page 11 Page 12 Page 13 Next page
Stibbe represents Mylan On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition
Stibbe advises Tornier Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.
Stibbe advises on the IPO of Pershing Square Holdings Stibbe advises Pershing Square Holdings, Ltd. on the IPO of this investment fund managed by the leading active investor Bill Ackmann.
Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.
Stibbe advises Investcorp on the acquisition of SPGPrints Stibbe advises Investcorp, a global provider and manager of alternative investment products, on its acquisition of SPGPrints Group from funds managed by Bencis Capital Partners.
Stibbe advises on the acquisition of an Intercontinental hotel portfolio including the landmark Amstel Hotel in Amsterdam Stibbe advised Katara Hospitality QSA (a subsidiary of the Qatar Investment Authority), the Qatar-based global owner, developer and operator of hotels, on the acquisition of five luxury InterContinental properties in key European cities.
Stibbe advises Aedifica Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence that will be constructed in Leersum. Aedifica acquired the full property of the site from Woudenburcht B.V., a local real estate developer. See for the press release here.
Stibbe represents Simed in dispute with Slotervaart hospital Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b
Stibbe advises US asset manager Stibbe advised a US asset manager on securing the acquisition of a real estate portfolio in France via a Luxembourg, non-regulated fund platform.
Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.
Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital.
Stibbe advises leading US car rental company Stibbe advised a leading US car rental company on Luxembourg company law aspects related to its acquisition of PSA Peugeot Citroën’s car rental subsidiary, Citer SA and its Spanish subsidiary Atesa through a Luxembourg structure.
Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.
Stibbe advises the Port of Antwerp Stibbe advised the Port of Antwerp International on its strategic partnership with Essar Ports Ltd. which is India’s second largest private sector ports operator, and on PAI's investment into EPL.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.